✦ LIBER ✦

Focus on the p53 gene and cancer: Advances in TP53 mutation research

✍ Scribed by Thierry Soussi

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 70 KB
Volume: 21
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.10191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of mutant p53 functional properti

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

✍ Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V. Tavtigian; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

The tumor suppressor gene TP53 is frequently mutated in human cancers. More than 75% of all mutations are missense substitutions that have been extensively analyzed in various yeast and human cell assays. The International Agency for Research on Cancer (IARC) TP53 database (www-p53.iarc.fr) compiles

Functional analysis of p53 gene and the

Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer

✍ Noriaki Sakuragi; Hidemichi Watari; Yasuhiko Ebina; Ritsu Yamamoto; Eric Steiner 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 182 KB 👁 1 views

## Abstract In addition to the loss of function, mutant p53 can possess a dominant‐negative effect on wild‐type p53 and may also exert gain‐of‐function activity. It is not clear whether the functional status of __p53__ mutation contributes to differences in outcome in endometrial cancer. We collect

Polymorphisms in drug metabolism genes,

Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer

✍ Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo

TP53 in gastric cancer: Mutations in the

TP53 in gastric cancer: Mutations in the L3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome

✍ Manuela Migliavacca; Laura Ottini; Viviana Bazan; Valentina Agnese; Simona Corsa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract The aim of this study was to clarify whether specific p53 mutations may have biological relevance in terms of disease relapse or death in gastric carcinomas (GC). Resected specimens from a consecutive series of 62 patients with GC undergoing potentially curative surgery were prospective

p53 Website and analysis of p53 gene mut

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

✍ Thierry Soussi; Karim Dehouche; Christophe Béroud 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

The p53 tumor suppressor gene has proven to be one of the genes most often mutated in human cancers. It involves mainly point mutations leading to amino acid substitutions in the central region of the protein which impairs normal functions. Analysis of the mutational events that target the p53 gene

DNA repair gene polymorphisms and probab

DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer

✍ Mariana C. Stern; Kathleen Conway; Yu Li; Kusum Mistry; Jack A. Taylor 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

We investigated if the presence of single nucleotide polymorphisms (SNPs) in the XRCC1, XRCC3, and XPD genes were associated with the type and frequency of p53 mutations in bladder cancer. Using a hospital-based case-control study we have previously reported risks for the XRCC1 codon 194, XRCC1 codo